Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen deal
May 16, 2023 at 07:54 AM EDT
The deal is bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.
